Jeng Wen-Juei, Kuo Ming-Chung, Shih Lee-Yung, Chu Pao-Hsien
The First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 199 Tun-Hwa North Road, Taipei, 105, Taiwan.
The Division of Hematology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Int J Hematol. 2008 Jun;87(5):542-544. doi: 10.1007/s12185-008-0071-x. Epub 2008 Apr 15.
Massive pulmonary embolism is an uncommon complication of multiple myeloma treated with thalidomide-dexamethasone regimen. In 2006, multiple myeloma was diagnosed in a 72-year-old man, who received thalidomide-dexamethasone therapy. In January 2007, echocardiography and computerized tomography identified massive pulmonary embolism in the pulmonary arteries and a deep vein thrombus of the right leg. The patient also had an elevated concentration of B-type natriuretic peptide. After heparinization and warfarin therapy, the patient's condition improved. This is the first report of a patient with a rare complication of pulmonary embolism from thalidomide-treated multiple myeloma.
大量肺栓塞是使用沙利度胺 - 地塞米松方案治疗的多发性骨髓瘤的一种罕见并发症。2006年,一名72岁男性被诊断为多发性骨髓瘤,接受了沙利度胺 - 地塞米松治疗。2007年1月,超声心动图和计算机断层扫描发现肺动脉存在大量肺栓塞以及右腿深静脉血栓。患者的B型利钠肽浓度也升高。经过肝素化和华法林治疗后,患者病情有所改善。这是首例关于沙利度胺治疗的多发性骨髓瘤出现罕见肺栓塞并发症患者的报告。